Conventional Versus Hypofractionated Radiation for High-Risk Prostate Cancer Patients (CHIRP): 24-Month Patient-Reported Outcomes of the Randomized Phase 2 CHIRP Trial
- 7 May 2022
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 114 (1), 99-107
- https://doi.org/10.1016/j.ijrobp.2022.04.045
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trialThe Lancet Oncology, 2016
- Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trialThe Lancet Oncology, 2016
- Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trialThe Lancet Oncology, 2015
- Differing Perceptions of Quality of Life in Patients With Prostate Cancer and Their DoctorsJournal of Urology, 2013
- Physical and Mental Impact of Psoriasis Severity as Measured by the Compact Short Form-12 Health Survey (SF-12) Quality of Life ToolJournal of Investigative Dermatology, 2012
- Adult measures of general health and health‐related quality of life: Medical Outcomes Study Short Form 36‐Item (SF‐36) and Short Form 12‐Item (SF‐12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF‐6D), Health Utilities Index Mark 3 (HUI3), Quality of Well‐Being Scale (QWB), and Assessment of Quality of Life (AQOL)Arthritis Care & Research, 2011
- Whole Pelvic Radiotherapy Versus Prostate Only Radiotherapy in the Management of Locally Advanced or Aggressive Prostate AdenocarcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2009
- An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancerEuropean Journal of Cancer, 2008
- Hypofractionation for Prostate Cancer: A Critical ReviewSeminars in Radiation Oncology, 2008
- Quality of Life Assessment Using the Short Form-12 (SF-12) Questionnaire in Patients With Cervical Spondylotic MyelopathySpine, 2006